News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Zymeworks Inc.
< Previous
1
2
3
Next >
Independent Proxy Advisory Firm ISS Recommends a Vote FOR the Zymeworks Redomicile
September 26, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Independent Proxy Advisory Firm Glass Lewis Recommends Zymeworks Shareholders Vote FOR Redomicile
September 16, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Reports Preliminary Phase 1 Trial Results for Zanidatamab Zovodotin (ZW49) at European Society for Medical Oncology Annual Congress
September 12, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Filing and Mailing of Materials for the Special Meeting to Approve Redomicile to Delaware
September 08, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Release of ESMO Abstract for Phase 1 Study of Zanidatamab Zovodotin (ZW49) in Solid Cancers
September 04, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Provides Corporate Update and Reports Second Quarter 2022 Financial Results
August 04, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
August 01, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Oral Presentation of Data from Phase 1 Study of Zanidatamab Zovodotin (ZW49) in Solid Cancers at European Society for Medical Oncology (ESMO) Congress 2022 in Paris
July 25, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Reports Inducement Grant to New Chief Scientific Officer
July 22, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks to Host Second Quarter Results Conference Call
July 21, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Plan to Become a Delaware Corporation
July 15, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Appoints Dr. Paul Moore as Chief Scientific Officer
June 27, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Adopts Limited-Duration Shareholder Rights Plan, Enabling All Shareholders to Realize Full Value of Company
June 10, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conference
May 27, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Clinical Data Demonstrating Promising Antitumor Activity with Zanidatamab in 1L Setting of HER2‑Positive Breast and Gastroesophageal Cancers to be Presented at ASCO 2022
May 26, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks’ Board of Directors Unanimously Rejects Unsolicited, Non-Binding Proposal
May 20, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Provides Corporate Update and Reports First Quarter 2022 Financial Results
May 04, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
May 02, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Confirms Receipt of Unsolicited, Non-Binding Proposal from All Blue Falcons
April 28, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Reports Last Patient Enrolled in Pivotal Study of Zanidatamab in Treatment of HER2-Expressing Late-Line Biliary Tract Cancer
April 28, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Presentations at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
April 27, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks to Host First Quarter 2022 Results Conference Call
April 19, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
April 01, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Provides Corporate Update and Reports Year-End 2021 Financial Results
February 24, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks to Host Fourth Quarter and Full Year 2021 Results Conference Call
February 08, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
February 03, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
January 31, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Pricing of $100.0 Million Public Offering
January 26, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Proposed Public Offering
January 26, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Provides Corporate Update on Key Strategic Priorities and Outlook for 2022
January 19, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.